Evidence map›Paper›PMID 38099195›Full record

ArticleFrontiers in molecular biosciences2023

Validation of potential RNA biomarkers for prostate cancer diagnosis and monitoring in plasma and urinary extracellular vesicles.

Agnese Brokāne, Cristina Bajo-Santos, Pawel Zayakin, Alberts Belovs, Juris Jansons, Vilnis Lietuvietis, Elena S Martens-Uzunova, Guido W Jenster, Aija Linē

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Circulating serum exosomes i-tRF-AspGTC and tRF-1-SerCGA as diagnostic indicators for non-small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  9. Advancements in Biomarkers of Prostate Cancer: A Review.Technology in cancer research & treatment
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Agnese BrokāneLatvian Biomedical Research and Study Centre, Riga, Latvia.
Cristina Bajo-SantosLatvian Biomedical Research and Study Centre, Riga, Latvia.
Pawel ZayakinLatvian Biomedical Research and Study Centre, Riga, Latvia.
Alberts BelovsRiga Stradiņš University, Riga, Latvia.
Juris JansonsRiga Stradiņš University, Riga, Latvia.
Vilnis LietuvietisRiga Stradiņš University, Riga, Latvia.
Elena S Martens-UzunovaDepartment of Urology, University Medical Center Rotterdam, Rotterdam, Netherlands.
Guido W JensterDepartment of Urology, University Medical Center Rotterdam, Rotterdam, Netherlands.
Aija LinēLatvian Biomedical Research and Study Centre, Riga, Latvia.
Latvian Biomedical Research and Study Centre · LVRiga Stradiņš University · LVRotterdam University of Applied Sciences · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

droplet digital PCRextracellular vesiclesliquid biopsiesprostate cancerRNA biomarkers

Identifiers

PMID38099195
PMCPMC10720733
OpenAlexW4389238064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.